ADA2 p.Ala69Thr
c.205G>A · rs374965869 · VCV1392684
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0704 | likely benign |
|---|---|---|
| REVEL | 0.023 | moderately benign-leaning |
| SaProt | LLR -7.23 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.27 | GERP -1.3 |
| Overall | ||
| CADD | 0.849 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0164% | 6,082 |
| Admixed American | 0.00667% | 14,993 |
| African / African-American | 0.00534% | 18,725 |
| East Asian | 0.00445% | 22,448 |
| European (non-Finnish) | 0.00178% | 56,191 |
| Finnishnot grpmax-eligible | 0.00156% | 64,016 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ADA2
- Protein
- p.Ala69Thr
- Coding
- c.205G>A
- MANE Select
- NM_001166105 · reported on NM_001282225
- dbSNP
- rs374965869
- Type
- single nucleotide variant
- Location
- chr22:17209473 (GRCh38)
- Structure
- AlphaFold pLDDT 85.04 · 1 PDB
Disease context
Sneddon syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: deficiency of adenosine deaminase 2
For Sneddon syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- Adult
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- ADA2 c.754-2A>G Likely pathogenic ★★ same condition
- ADA2 c.882-2A>G Pathogenic ★★ same condition
- ADA2 c.973-2A>G Pathogenic ★★ same condition
- ADA2 p.Arg169Gln Pathogenic/Likely pathogenic ★★ ⚠ same condition
- ADA2 p.Arg169Trp Pathogenic/Likely pathogenic ★★ same condition
- ADA2 p.Arg306Ter Likely pathogenic ★★ same condition
- ADA2 p.Arg312Ter Pathogenic ★★ same condition
- ADA2 p.Asn370Lys Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ada2-p-ala69thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown